Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 — St. Petersburg, Florida

Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 is a clinical research site located in St. Petersburg, Florida, United States 33709-3113.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 has participated in 1 clinical trials.

Therapeutic areas: Heavy Menstrual Bleeding, Uterine Fibroids.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913?

Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 conducted?

Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 has 1 clinical trials on record. Their work covers Heavy Menstrual Bleeding, Uterine Fibroids.

Is Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 accredited by Crixeo Health?

Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accel Research Sites - St Petersburg Clinical Research Unit /ID# 160913?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.